ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 7 filers reported holding ERYTECH PHARMA in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,414 | +12.0% | 17,006 | +50.4% | 0.00% | – |
| Q1 2023 | $11,081 | -11.4% | 11,307 | -70.2% | 0.00% | – |
| Q4 2022 | $12,507 | +25.1% | 37,889 | +108.4% | 0.00% | – |
| Q3 2022 | $10,000 | -93.2% | 18,181 | -86.5% | 0.00% | – |
| Q2 2022 | $148,000 | -75.0% | 134,992 | -58.4% | 0.00% | – |
| Q1 2022 | $591,000 | -32.9% | 324,573 | -13.0% | 0.00% | – |
| Q4 2021 | $881,000 | +948.8% | 373,125 | +2461.8% | 0.00% | – |
| Q3 2021 | $84,000 | +3.7% | 14,565 | +28.4% | 0.00% | – |
| Q1 2021 | $81,000 | – | 11,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| StoneX Group Inc. | 17,304 | $13 | 0.00% |
| Baader Bank Aktiengesellschaft | 24,000 | $14,716 | 0.00% |
| Vanguard Personalized Indexing Management, LLC | 24,271 | $18,689 | 0.00% |
| Citadel Advisors | 400 | $292 | 0.00% |
| Citadel Advisors | 16,606 | $12,122 | 0.00% |
| Asset Dedication, LLC | 4,000 | $3 | 0.00% |
| Ikarian Capital, LLC | 3,019 | $2,257 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 10,590 | $7,731 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 12,069 | $8,810 | 0.00% |